Close Menu


The partners aim to enable automatic processing from a wide range of sample types, such as nucleic acids extracted from sorted cells, fine needle aspirates, formalin-fixed paraffin embedded tissue, and other limited or degraded clinical samples.

New Products: Feb 1, 2011


DNAStar's SeqMan NGen3, Halo Genomics' targeted resequencing kit, NuGen's Ovation Prokaryotic RNA-seq System, and the Sanger Institute's COSMIC version 51

The companies will develop and market automated next-gen sequencing sample prep methods on Caliper's Sciclone NGS workstation.

The firms will co-develop automation scripts for NuGen's Ovation RNA-Seq System and Encore NGS Multiplex System I on Caliper's Sciclone NGS Workstation.

New Product Watch: Jan 25, 2011


NanoString Technologies' nCounter Mouse miRNA Expression Assay Kit, Tecan's HydroSpeed Plate Washer, TriLink Biotechnologies' CleanAmp 7-deaza-dGTP Kit

The agreement builds upon an existing OEM pact between the companies under which Tecan is manufacturing and will help market Enigma's forthcoming Enigma ML testing device for the point-of-care and low-complexity laboratory markets.

Tecan has licensed molecular diagnostics technology from Enigma Diagnostics.

The firms will co-market Covaris' Adaptive Focused Acoustics systems with Tecan's Freedom EVO liquid handling instruments.

Product Watch: Nov 4, 2010


Qiagen's FFPE kits, NuGen's Ovation FFPE kits, NanoString's nCounter Copy Number Variation CodeSets, Illumina's TruSeq sample-prep kits, the Agilent SureSelect XT Target Enrichment System

New Products: Nov 2, 2010


NuGen's Ovation WGA FFPE and Ovation RNA-Seq FFPE systems and BioNanomatrix's nanoAnalyzer 1000 System.


New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.